Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency
about
3D reconstruction of VZV infected cell nuclei and PML nuclear cages by serial section array scanning electron microscopy and electron tomographySynaptic Plasticity and Neurological Disorders in Neurotropic Viral InfectionsThe inflammasome as a target of modulation by DNA virusesCost of shingles: population based burden of disease analysis of herpes zoster and postherpetic neuralgiaVaricella-zoster virus immediate-early protein ORF61 abrogates the IRF3-mediated innate immune response through degradation of activated IRF3Pseudorabies virus infection alters neuronal activity and connectivity in vitroPrevention strategies for herpes zoster and post-herpetic neuralgiaVaricella-zoster virus human ganglionic latency: a current summary.Varicella Zoster Virus Infection of the Central Nervous System - 10 Year Experience from a Tertiary Hospital in South India.Entrapment of viral capsids in nuclear PML cages is an intrinsic antiviral host defense against varicella-zoster virus.Emerging drugs for varicella-zoster virus infections.CD4 T cell immunity is critical for the control of simian varicella virus infection in a nonhuman primate model of VZV infection.Asymptomatic reactivation and shed of infectious varicella zoster virus in astronauts.Presentation and management of herpes zoster (shingles) in the geriatric population.Herpes zoster: diagnostic, therapeutic, and preventive approaches.Upregulation of CXCL10 in human dorsal root ganglia during experimental and natural varicella-zoster virus infection.One-year follow-up of patients with long-lasting post-herpetic neuralgia.The short- and long-term risk of stroke after herpes zoster - a nationwide population-based cohort study.Varicella-zoster virus infection triggers formation of an interleukin-1β (IL-1β)-processing inflammasome complexA nationwide population-based cohort study to identify the correlation between heart failure and the subsequent risk of herpes zoster.The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study.Heat-Labile Enterotoxin IIa, a Platform To Deliver Heterologous Proteins into Neurons.Effector and Central Memory Poly-Functional CD4(+) and CD8(+) T Cells are Boosted upon ZOSTAVAX(®) VaccinationPatients with an acute zonal occult outer retinopathy-like illness rapidly improve with valacyclovir treatment.Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly.Newly developed urinary retention and motor weakness of lower extremities in a postherpetic neuralgia patientIntravenous vitamin C in the treatment of shingles: results of a multicenter prospective cohort study.Genetic analysis of clinical VZV isolates collected in China reveals a more homologous profileAssociation between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases.Cost of Herpes Zoster in Patients With Selected Immune-Compromised Conditions in the United States.Herpes zoster infection increases the risk of peripheral arterial disease: A nationwide cohort study.HIV interactions with monocytes and dendritic cells: viral latency and reservoirs.Varicella-zoster virus glycoprotein I is essential for spread in dorsal root ganglia and facilitates axonal localization of structural virion components in neuronal cultures.Analysis of human alphaherpesvirus microRNA expression in latently infected human trigeminal ganglia.A 46-year-old female presenting with worsening headache, nuchal rigidity and a skin rash in varicella zoster virus meningitis: a case reportThree cases of mumps virus and enterovirus coinfection in children with enteroviral meningitis.Incidence of herpes zoster in patients with altered immune function.VZV infection of keratinocytes: production of cell-free infectious virions in vivoDisarming Cellular Alarm Systems-Manipulation of Stress-Induced NKG2D Ligands by Human Herpesviruses.IVIG treatment for VZV-related acute inflammatory polyneuropathy in a child.
P2860
Q27345336-A2FC3B51-E790-4B1C-B0C9-9D8F5737B92BQ28088477-1AA7AD5F-EA47-48EA-B496-4C280B873D03Q28388139-3F26A8CA-AE12-4975-94AE-16AA58A711ECQ28468596-FC70F55B-84C9-4799-96F9-B1774AF1A7C3Q28743826-4E6AC20A-E0AB-48DC-8625-E7F91E69A425Q33513969-C185E44E-1B6D-4883-A567-675559DA3F82Q33562809-D794B460-C228-46C1-94EE-C3B583D615F1Q33704274-08FCA70D-B62A-4FBD-962A-9A832ABB1FD5Q33795518-7247AE6D-0636-48AD-A79F-9C0B48F1067BQ33815559-6640D7F0-71CC-406A-AFB0-E6CE9050FA4FQ34027426-D5C2D279-820A-46A6-B4FE-724FD6D2AE29Q34079162-DC1E215D-92C7-48AF-BE1A-421DD2311E84Q34124505-F7AE8ED4-6AC9-4863-9D65-A692CECAD4FBQ34352218-9E5C82AC-8C34-4651-946C-6766AD69E9E3Q34376752-CDCB1B02-AB63-416B-8D61-B85422FB221EQ34457932-11E06C51-9B2F-4997-8B53-8D2E5D97BECFQ34484576-91D33E36-22F0-4B84-B366-04CC3E6141B6Q34853183-62E4C214-4BB0-4773-9AAA-657FFE121EC4Q34979025-E77961A0-AF2D-4744-BE37-C41D5616F68AQ35016212-3C89B6E8-79FC-4F2B-BA57-D44BA5C2F811Q35840824-0867D543-EFBE-461B-B513-ED9BB99C5B36Q35973003-F5F33B86-71EA-4A38-B1F1-AFF384278FFFQ36237622-520C9498-9596-4B6D-9C12-F7FEE34798A4Q36347480-0190283A-E6EC-493C-81A5-313A9C0CDE7EQ36511529-6D31E258-0F18-4890-985E-18DE267A867BQ36536801-7B287167-563A-4F48-A1F1-814C7319EBF9Q36577734-B7660B4A-7F13-47D8-BAC5-18645343ABFDQ36918399-ABA37186-0E9C-4A91-A8BF-4FDFA62EF1B2Q36932760-908E801C-A2AE-4BE2-81B7-C3967E89739DQ37091674-6D0C2F15-CD37-4D0E-9D1B-CD896FDA89EDQ37226172-2FCA390A-236F-4E64-B260-377B9B0EA776Q37229398-707D2A29-EB72-4D67-8099-0380B2E7C325Q37336873-B8C663B0-A684-4A12-99B0-E9A632985530Q37365331-F0DEF823-7CBB-4EC1-81EF-5877E34B90FEQ37403348-FAEF0E21-CFAF-4B88-B9C0-D68C9B20BC55Q37606185-34DC83BB-5BD0-44EA-A2AF-C1529BC61813Q37670193-925C7EE9-5EEC-4FFE-819A-80F9156744EBQ37708084-12D65B5D-1B02-4074-A578-CCD9A0A876E2Q37747044-36282BF7-5F6E-4067-942F-7CAAA77A69FFQ38027782-095BAC36-55A8-441A-9FB4-87B1BC5ED278
P2860
Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Varicella zoster virus infecti ...... enesis of disease, and latency
@ast
Varicella zoster virus infecti ...... enesis of disease, and latency
@en
Varicella zoster virus infecti ...... enesis of disease, and latency
@nl
type
label
Varicella zoster virus infecti ...... enesis of disease, and latency
@ast
Varicella zoster virus infecti ...... enesis of disease, and latency
@en
Varicella zoster virus infecti ...... enesis of disease, and latency
@nl
prefLabel
Varicella zoster virus infecti ...... enesis of disease, and latency
@ast
Varicella zoster virus infecti ...... enesis of disease, and latency
@en
Varicella zoster virus infecti ...... enesis of disease, and latency
@nl
P2093
P2860
P1433
P1476
Varicella zoster virus infecti ...... enesis of disease, and latency
@en
P2093
Donald H Gilden
Maria A Nagel
Randall J Cohrs
Ravi Mahalingam
P2860
P304
675-97, viii
P356
10.1016/J.NCL.2008.03.011
P577
2008-08-01T00:00:00Z